Koers Dna Group (T.R.) Ltd TEL AVIV STOCK EXCHANGE
Aandelen
DNA
IL0011038523
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 0,56 2,09 0,52 | Omzet 2023 | 0,31 1,14 0,29 | Marktkapitalisatie | 77,84 mln. 291 mln. 72,78 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -23 mln. -85,84 mln. -21,51 mln. | Nettowinst (verlies) 2023 | -1 mln. -3,73 mln. -935K | EV/omzet 2022 | 38.063.516 x |
Nettoliquiditeiten 2022 | 65,73 mln. 245 mln. 61,46 mln. | Nettoliquiditeiten 2023 | 66,7 mln. 249 mln. 62,36 mln. | EV/omzet 2023 | 36.410.820 x |
K/w-verhouding 2022 |
-3,6
x | K/w-verhouding 2023 |
-63,2
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 45,14% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ori Altschuler
CEO | Chief Executive Officer | 41 | 18-01-22 |
Klein Tony Hanan
DFI | Director of Finance/CFO | 44 | 15-11-15 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 27-04-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Orit Stav
BRD | Director/Board Member | 53 | 20-10-22 |
Erez Navon
CHM | Chairman | 50 | 24-02-21 |
Ronen Midbari
BRD | Director/Board Member | 49 | 19-03-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,08% | 42,68 mld. | |
+0,67% | 42,4 mld. | |
+46,56% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,55% | 24,94 mld. | |
-21,66% | 18,96 mld. | |
+29,96% | 12,3 mld. | |
-1,57% | 11,95 mld. | |
-4,80% | 11,55 mld. |